Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Paroxetine hydrochloride enteric-coated and sustained-release tablet and its preparation method

A technology of paroxetine hydrochloride and sustained-release tablets, which is applied in the direction of pharmaceutical formulas, medical preparations with no active ingredients, medical preparations containing active ingredients, etc., and can solve problems such as large individual differences, stability changes, and uncontrollability , to achieve significant controlled release characteristics, solve the problem of drug residues, and increase the effect of heat resistance and stability

Inactive Publication Date: 2018-06-12
HEFEI HUAFANG PHARMA SCI & TECH
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Because the Paroxetine Hydrochloride Sustained-release Preparation developed by GlaxoSmithKline (GSK) adopts a skeleton erosion structure, the release and absorption rate of the drug are also affected by factors such as the gastrointestinal fluid in the patient's body, so its blood drug concentration remains the same. There are large fluctuations, difficult to control and predict, and have a certain degree of uncertainty. The duration of effective effects and the magnitude of side effects also vary from person to person, with large individual differences and uncontrollable
[0005] Osmotic pump-type controlled-release preparations use osmotic pressure as the driving force for drug release and are characterized by zero-order release kinetics. The most widely used is the dual-chamber osmotic pump controlled-release tablet, but most of the dual-chamber osmotic pump tablets are currently on the market. Type osmotic pump controlled-release tablets have the following defects: (1) The preparation process is special, and the production cost is relatively high
(2) The thermal stability of the main auxiliary materials of the tablet core is poor
Polyoxyethylene is used as the main auxiliary material for dual-chamber osmotic pump controlled-release tablets. It has poor thermal stability and a low glass transition temperature (62-67°C). After granulation, the drying temperature should not exceed 40°C, which is prone to excessive solvent residues. , and in the tableting process, it is necessary to install a special device to cool down the tableting machine. At the same time, the storage conditions of the preparation are relatively high, and improper storage is prone to changes in the stability of the storage process.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Paroxetine hydrochloride enteric-coated and sustained-release tablet and its preparation method
  • Paroxetine hydrochloride enteric-coated and sustained-release tablet and its preparation method
  • Paroxetine hydrochloride enteric-coated and sustained-release tablet and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A kind of paroxetine hydrochloride enteric-coated enteric-coated slow-release tablet, every 1000 tablets are prepared with the following raw materials and auxiliary materials:

[0035] Chip raw material:

[0036]

[0037] Raw material of isolation layer:

[0038] Hydroxyethylcellulose 6g

[0039] Polyethylene glycol 0.3g

[0040] Semi-permeable membrane material:

[0041] Cellulose acetate 10g

[0042] Macrogol 400 3.2g

[0043] Raw material of enteric coating:

[0044] L30D-55 8.5g

[0045] Triethyl citrate 0.25g

[0046] Talc powder 0.85g

[0047] Moisture-proof clothing raw materials:

[0048] Opadry 13B150000 PINK 3.6g

[0049] The preparation method of the paroxetine hydrochloride enteric-coated enteric-coated sustained-release tablet comprises the following steps:

[0050] S1. Mix paroxetine hydrochloride with a particle size of 10 μm, lactose, microcrystalline cellulose 101, and povidone k30, add purified water to moisten, granulate through a 24-mesh ...

Embodiment 2

[0057] A kind of paroxetine hydrochloride enteric-coated enteric-coated slow-release tablet, every 1000 tablets are prepared with the following raw materials and auxiliary materials:

[0058] Chip raw material:

[0059]

[0060] Raw material of isolation layer:

[0061] Hydroxyethylcellulose 6g

[0062] Polyethylene glycol 3350 0.3g

[0063] Semi-permeable membrane material:

[0064] Cellulose acetate 9g

[0065] Macrogol 400 3g

[0066] Raw material of enteric coating:

[0067] L30D-55 8.5g

[0068] Triethyl citrate 0.25g

[0069] Talc powder 0.85g

[0070] Film coating material:

[0071] Opadry 13B150000 PINK 3.6g

[0072] The preparation method of the paroxetine hydrochloride enteric-coated enteric-coated sustained-release tablet comprises the following steps:

[0073] S1. Mix paroxetine hydrochloride with a particle size of 15 μm, lactose, microcrystalline cellulose 101, and povidone k30, add purified water to moisten, granulate through a 40-mesh sieve, dry, ...

Embodiment 3

[0080] A kind of paroxetine hydrochloride enteric-coated enteric-coated slow-release tablet, every 1000 tablets are prepared with the following raw materials and auxiliary materials:

[0081] Chip raw material:

[0082]

[0083]

[0084] Raw material of isolation layer:

[0085] Hydroxyethylcellulose 6g

[0086] Polyethylene glycol 3350 0.3g

[0087] Semi-permeable membrane material:

[0088] Cellulose acetate 10g

[0089] Macrogol 400 3.2g

[0090] Raw material of enteric coating:

[0091] L30D-55 8.5g

[0092] Triethyl citrate 0.25g

[0093] Talc powder 0.85g

[0094] Moisture-proof clothing raw materials:

[0095] Opadry 13B150000 PINK 3.6g

[0096] The preparation method of the paroxetine hydrochloride enteric-coated enteric-coated sustained-release tablet comprises the following steps:

[0097] S1. Mix paroxetine hydrochloride with a particle size of 50 μm, lactose, microcrystalline cellulose 101, and povidone k30, add purified water to moisten, granulate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a paroxetine hydrochloride enteric-coated and sustained-release tablet, which comprises a tablet core, an isolating layer, a semipermeable membrane, an enteric coating and a moistureproof coat; the isolating layer is arranged between the tablet core and the semipermeable membrane, the enteric coating is arranged between the semipermeable membrane and the moistureproof coat,wherein the tablet core is prepared from paroxetine hydrochloride, penetrating agent, filling agent, binding agent and lubricant; the penetrating agent comprises one or more drug release hole. The invention further provides a preparation method of the paroxetine hydrochloride enteric-coated and sustained-release tablet, which includes steps of preparing tablet core grains and performing compression moulding to obtain the tablet core; making the tablet core pass through the isolating layer, the emipermeable membrane, the enteric coating and moistureproof coat, drying to obtain the paroxetine hydrochloride enteric-coated and sustained-release tablet. The paroxetine hydrochloride enteric-coated and sustained-release tablet can effectively control the drug release rate, and keep stable blooddrug concentration and durable drug effect, increase the safety, effectiveness and compliance of patients after taking drugs; the production preparation technique is simple, and the cost is low.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a paroxetine hydrochloride enteric-coated sustained-release tablet and a preparation method thereof. Background technique [0002] Paroxetine is a selective serotonin reuptake inhibitor (SSRI) type antidepressant used to treat depression, obsessive-compulsive disorder, panic disorder or social anxiety disorder. [0003] The earliest common preparation of this product on the market has serious adverse reactions in the gastrointestinal tract and poor compliance. Therefore, an enteric-coated sustained-release preparation that is taken once a day has been launched abroad. Paroxetine hydrochloride enteric-coated sustained-release tablets are developed by GlaxoSmithKline (GSK), under the trade name CR is marketed and clinically used for the treatment of severe depression, panic disorder (with or without place phobia), social anxiety disorder and premenstrual anxiety disorder. Ent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/22A61K9/44A61K47/12A61K47/26A61K47/38A61K47/10A61K31/4525A61P25/24A61P25/22A61P25/00
CPCA61K9/2013A61K9/2018A61K9/2072A61K9/2853A61K9/2866A61K9/2886A61K31/4525
Inventor 杨贤龙何勇吴宗好
Owner HEFEI HUAFANG PHARMA SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products